News
What to do when sudden right rib pain strikes
Sudden sharp pain under the right rib cage can be alarming and uncomfortable.
This area of the body contains several important organs, such as the liver, gallbladder, and parts of the intestines, as well as muscles and the lower ribs themselves.
The pain can range from a dull ache to a severe stabbing sensation.
Proper response to right rib pain depends on its severity, duration, and any other symptoms that appear with it.
Most cases stem from muscle strain, digestive issues, or gallbladder problems. However, some situations require urgent medical care.
This guide helps readers understand what steps to take once right rib pain starts, from simple home remedies to recognizing warning signs that demand immediate professional attention.
Assess the pain: note intensity, location, and any accompanying symptoms like fever or jaundice
The first step involves a careful evaluation of the pain itself. A person should note where exactly the discomfort occurs, like whether the sharp pain under right rib cage feels direct or spreads to other areas.
The intensity matters too, and patients can rate it on a scale from 1 to 10 to help describe how severe it feels.
Other symptoms provide important clues about what causes the pain. Fever may suggest an infection in the gallbladder, liver, or lungs. Jaundice, which appears as yellow skin or eyes, often points to liver or gallbladder problems.
Additional signs to watch include nausea, vomiting, trouble breathing, or pain that moves to the shoulder or back. Someone should also pay attention to what makes the pain worse or better, such as movement, deep breaths, or meals.
This information helps doctors identify the source and decide on the right treatment.
Avoid heavy meals and fatty foods to reduce gallbladder strain if pain is related to digestion
The gallbladder stores and releases bile to help break down fats during digestion. If sudden right rib pain appears after eating, the gallbladder may be the source of discomfort.
Heavy, fatty foods force the gallbladder to work harder. This extra effort can trigger pain, especially if gallstones or inflammation exist. Fried foods, greasy meats, and rich sauces are common triggers.
A low-fat diet gives the gallbladder time to rest and recover. People should focus on lean proteins, whole grains, and fresh vegetables instead. These lighter options put less stress on the digestive system.
Small, frequent meals work better than large portions. This approach helps the body process food without overwhelming the gallbladder. Fiber-rich foods also support better digestion and may help prevent future issues.
If pain continues despite dietary changes, medical attention becomes necessary. However, simple food adjustments often provide quick relief for gallbladder-related discomfort.
Apply a warm compress to the right rib cage area to relieve muscle strain or stiffness
A warm compress can help ease right rib pain caused by muscle strain or stiffness. Heat therapy increases blood flow to the affected area, which helps muscles relax and reduces tension.
This method works well for pain that comes from overuse, poor posture, or minor injuries.
To apply heat safely, use a heating pad or warm compress on the painful area for 15 to 20 minutes at a time. The temperature should feel comfortable, not hot enough to burn the skin. #
People can repeat this process several times throughout the day as needed.
Heat therapy works best after the first 48 hours of an injury. For fresh injuries, ice usually provides better relief.
However, for ongoing stiffness or chronic muscle tension around the ribs, warmth offers significant comfort.
The heat helps tight muscles loosen up, which makes it easier to breathe deeply and move around. Many people notice less pain and improved flexibility after just one or two sessions.
Take over-the-counter pain relievers like ibuprofen if there are no contraindications
Over-the-counter pain relievers can help manage sudden right rib pain. Ibuprofen and acetaminophen are two common options that work well for many people.
Ibuprofen reduces pain and also fights inflammation. This makes it useful for rib pain caused by muscle strain or injury.
Acetaminophen works differently because it only relieves pain without reducing inflammation.
However, not everyone can safely take these medications. People with certain health conditions should avoid ibuprofen, including those with stomach ulcers, kidney problems, or heart disease.
Acetaminophen can harm the liver if someone takes too much or already has liver issues.
The person should read the label carefully and follow the recommended dose. Taking more than directed does not provide better relief and can cause serious health problems.
If pain continues after a few days of treatment, a doctor visit becomes necessary.
Seek immediate medical attention if pain is severe, persistent, or accompanied by shortness of breath or trauma
Severe right rib pain requires urgent medical care in certain situations. If the pain comes on suddenly and feels intense, a person should call 911 or go to the emergency room right away.
Difficulty breathing or shortness of breath alongside rib pain signals a serious problem.
This combination may point to a collapsed lung, blood clot, or other life-threatening condition that needs immediate treatment.
Anyone who experiences rib pain after an injury or accident should seek emergency help. A fall, car crash, or direct blow to the chest can cause broken ribs or internal damage.
These injuries may not show obvious signs at first but can become dangerous.
Pain that persists for more than a few minutes or continues to worsen also warrants medical attention. Additional warning signs include chest pressure, dizziness, confusion, or pain that spreads to other areas.
These symptoms suggest the problem extends beyond a simple muscle strain and requires professional evaluation.
Conclusion
Sudden right rib pain can happen for many different reasons. The cause might be as simple as a muscle strain or as serious as a problem with the liver or gallbladder.
People should pay attention to how bad the pain feels and whether other symptoms appear alongside it.
Anyone who experiences severe pain, trouble breathing, or symptoms that last more than a few days should see a doctor right away.
Quick action can make a big difference in treatment and recovery.
Women with osteoporosis may be more likely to carry a gene linked to Alzheimer’s, according to new research.
Scientists found that APOE4, the most common genetic risk factor for Alzheimer’s, can weaken bone quality in women, even when standard scans appear normal.
The study, carried out by researchers at the Buck Institute for Research on Ageing in California, US, and UC San Francisco, suggests the gene may damage bone at a microscopic level long before any visible signs.
These changes can emerge as early as midlife and remain invisible to routine imaging tests used to assess bone strength.
The findings suggest a link between Alzheimer’s risk and skeletal health and could help pave the way for earlier detection of both conditions.
Professor Birgit Schilling, a senior author of the study, said: “What makes this finding so striking is that bone quality is being compromised at a molecular level that a standard bone scan simply will not catch.
“APOE4 is quietly disrupting the very cells responsible for keeping bone strong – and it is doing this specifically in females, which mirrors what we see with Alzheimer’s disease risk.”
Doctors have long observed that people with Alzheimer’s suffer higher rates of bone fractures, while osteoporosis in women is known to be one of the earliest predictors of the disease.
Now scientists believe they may have uncovered why.
Researchers led by Dr Charles Schurman carried out a detailed analysis of proteins in aged mouse bone and found that tissue was unusually rich in molecules linked to neurological disease, including those associated with Alzheimer’s.
In particular, long-lived bone cells known as osteocytes showed elevated levels of APOE, with levels twice as high in older female mice compared with younger or male animals.
Further experiments using genetically modified mice revealed that APOE4 had a strong and sex-specific impact on both bone and brain tissue.
The disruption at the protein level was even greater in bone than in the brain.
However, the bone structure itself appeared completely normal under scans.
Instead, the gene interfered with a key maintenance process inside bone cells, preventing them from repairing microscopic channels that keep bones strong and resilient.
When this process breaks down, bones become more fragile even if they look healthy on standard imaging.
These results suggest bone cells could potentially act as early biological warning signs of cognitive decline in women carrying APOE4.
Professor Lisa Ellerby, another senior author, said: “We think targeting these cells may open a new front in preserving bone quality in this population.”
Experts say the findings highlight the need to view the body as an interconnected system rather than treating diseases in isolation.
Dementia, of which Alzheimer’s is the most common form, remains one of the UK’s biggest health challenges.
Around 900,000 people are currently living with the condition, a figure expected to rise to 1.6 million by 2040.
It is already the leading cause of death, responsible for more than 74,000 deaths each year.
Health secretary Wes Streeting has relaunched England’s women’s health strategy, vowing to stop women being “gaslit” by doctors.
Speaking before publication of the renewed strategy, the health secretary said the NHS was “failing women” and set out measures to help them access the healthcare they need.
The government said the strategy would include a new standard of care to ensure women were offered pain relief for invasive procedures, such as fitting a contraceptive coil and hysteroscopies.
Feedback would be directly linked to provider funding through a new trial, giving women more power to affect change if they have a poor experience.
Action would also be taken to ensure women no longer face long waits for diagnoses for conditions such as endometriosis, which can take a decade to diagnose.
Streeting said: “[Women] have for so long been let down by a healthcare system that too often gaslights women, treating their pain as an inconvenience and their symptoms as an overreaction.
“Whether it’s being passed from one appointment to another for conditions like endometriosis and fibroids, or a lack of proper pain relief during invasive procedures, through to having to navigate symptoms for years before receiving a diagnosis, it’s clear the system is failing women.
“Women’s voices must be central to delivering effective, respectful and empathetic care. We need to hit medical misogyny where it hurts – the wallet.
“Today’s renewed strategy will tackle the issues women face every day and ensure no woman is left fighting to be heard.”
A report last month by the women and equalities committee found that gynaecological and menstrual health had not been “sufficiently prioritised” by the government.
MPs said parts of the 10-year women’s health strategy, launched in 2022 by the Conservatives, were at risk of being scaled back or discontinued under wider changes to the NHS.
These included initiatives that had reduced waiting lists and improved women’s access to healthcare, such as women’s health hubs.
Sarah Owen, chair of the committee and a Labour MP, said: “This would be a disaster for girls’ and women’s menstrual healthcare, when it is in dire need of more support.
“It is a national scandal that nearly half a million women are on hospital gynaecology waiting lists when there are effective treatments that could be administered in primary and community care, if only they could access them.”
The report said women faced “medical misogyny” and were left to “suck it up” and suffer in pain for years because of a lack of awareness of women’s health conditions.
A redesign of clinical pathways for some women’s health issues will aim to speed up diagnosis and treatment, and there will be a review of support for families who experience repeated baby loss.
The government also promised a “single referral point” to ensure women were directed to the right place the first time they sought help.
Dr Sue Mann, NHS England’s women’s health director, said too many women were dismissed for “serious symptoms” that affected every part of their lives.
“The renewed women’s health strategy will build significantly on the work the NHS has been doing to ensure women are heard and get the specialist care they need,” she said.
Women’s health groups cautiously welcomed the renewed strategy. Emma Cox, chief executive of Endometriosis UK, said decisive action would be vital to improve women’s healthcare in England.
Future Fertility, a Toronto-based health technology company specialising in AI-powered fertility insights, has entered the Japanese market through a new commercial partnership with Kato Ladies Clinic — a globally recognised leader in IVF research and advancing clinical fertility care.
The collaboration marks Future Fertility’s first partnership in Japan and reflects growing global demand for technologies that bring greater objectivity and personalisation to fertility care.
Kato Ladies Clinic will integrate the company’s AI-powered oocyte (egg) quality assessment tools into its clinical workflows, with the aim of supporting more informed treatment planning and patient counselling across IVF and egg freezing cycles.
“At Kato Ladies Clinic, we are committed to advancing fertility care through innovation while maintaining a strong focus on individualised, patient-centred treatment,” said Keiichi Kato, chief executive officer.
“Partnering with Future Fertility enables us to integrate objective, data-driven insights into our clinical approach and better support our patients in making informed decisions.”
Future Fertility’s platform analyses images of oocytes using artificial intelligence trained and validated on a dataset of more than 650,000 unique oocyte images.
The technology is already in use at more than 300 clinics across more than 35 countries, helping clinicians better understand the developmental potential of individual eggs and provide patients with more personalised insight earlier in their treatment journey.
From Research Collaboration to Clinical Adoption
The partnership between Future Fertility and Kato Ladies Clinic began as a scientific research collaboration in 2024, marking the first use of AI-powered oocyte quality assessment in Japan.
The collaboration not only validated the technology in a new patient population and across diverse clinical protocols — including minimal stimulation cycles —but also resulted in a peer-reviewed publication in Reproductive BioMedicine Online (RBMO) and a poster abstract presentation at ESHRE 2025.
The joint research explored how AI-derived oocyte quality scores relate to early embryonic development and overall treatment outcomes. In a retrospective study conducted at Kato Ladies Clinic, researchers analysed nearly 2,800 mature oocytes across more than 1,300 ICSI cycles, linking image-based assessments of egg quality to key developmental milestones.
The study demonstrated that lower AI scores were associated with reduced fertilization rates, delays, and abnormalities in early embryo development, increased developmental errors, and lower-quality blastocyst formation.
Notably, the researchers also found that cumulative oocyte scores were a stronger predictor of live birth outcomes than the number of eggs retrieved — underscoring the importance of assessing egg quality alongside quantity.
“Our collaboration with Future Fertility has demonstrated how artificial intelligence can uncover meaningful biological differences between oocytes that were previously difficult to quantify,” said Kenji Ezoe, senior scientist.
“Bringing this technology into routine clinical use is an important step toward translating research into improved patient outcomes.”
Future Fertility’s VP of clinical embryology & scientific operations, Jullin Fjeldstad, noted that the findings provide important clinical validation.
“Our joint research with Kato Ladies Clinic has shown how AI-based oocyte assessment can be directly linked to numerous embryo development outcomes, from fertilization through early developmental milestones and blastocyst formation,” she said.
“We are excited to see this work translated into clinical practice.”
Growing Demand for Fertility Care in Japan
The partnership comes at a time when demand for fertility treatment in Japan continues to rise.
The country performs over 450,000 fertility treatment cycles annually, making it one of the largest markets globally. Delayed childbearing and evolving societal trends have also contributed to increasing interest in egg freezing.
As patients seek more clarity and personalization in their care, tools that provide earlier insight into reproductive potential are gaining traction.
“Entering the Japanese market with a partner like Kato Ladies Clinic is a significant step forward for our global commercial strategy,” said Rafael Gonzalez, Future Fertility’s VP of global sales & strategy.
“It reflects the growing demand for technologies that support more transparent, data-driven fertility care across diverse healthcare systems.”
Expanding a Global Footprint
Founded in 1993, Kato Ladies Clinic is known for its pioneering work in natural and minimal stimulation IVF and has long been a leader in clinical innovation in Japan.
For Future Fertility, the partnership represents both a geographic expansion and a continuation of its broader mission to bring AI-driven insights into routine fertility care.
“We are proud to partner with Kato Ladies Clinic, a globally respected leader in IVF and a pioneer in reproductive medicine in Japan,” said Future Fertility’s CEO, Christy Prada.
“This partnership represents an important milestone as we expand into Asia and continue our mission to bring objective, personalised insights into fertility care worldwide.”
Future Fertility develops AI-powered tools designed to generate personalised insights across the fertility journey.
Its flagship oocyte assessment technologies analyse egg images to provide objective, individualised measures of egg quality, supporting treatment planning, patient counselling, and clinical decision-making in egg freezing and IVF, while also enabling more data-driven approaches to donor egg distribution and quality assurance.
As fertility care continues to evolve, collaborations like this one are helping shape a new standard — one that emphasises earlier insight, greater transparency, and more personalised decision-making for patients navigating increasingly complex reproductive journeys.
Entrepreneur2 weeks agoThree sessions that show exactly where women’s health is heading in 2026
News4 weeks agoLuna and Kindbody partner to bring data-driven insight to women’s health and fertility care
News4 weeks agoFemtech World Awards announces deadline extension
Fertility4 weeks agoMenstruation costs £20,359 a lifetime, sparking calls for Government action
Menopause3 weeks agoCalifornia plans US$3.4m menopause care overhaul
News4 weeks agoHalogen Ventures surpasses 100 investments in female-founded startups
Menopause3 weeks agoWatchdog bans five ads for women’s heath claims
Pregnancy2 weeks agoHow NIPT has evolved and what AI NIPT means in 2026